会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 12. 发明申请
    • QUANTIFICATION OF GENE EXPRESSION
    • 量化基因表达
    • WO2004022721A3
    • 2004-09-16
    • PCT/US0328081
    • 2003-09-05
    • UNIV BOSTONCANTOR CHARLES RDING CHUNMING
    • CANTOR CHARLES RDING CHUNMING
    • G01N33/50C12N20060101C12N15/09C12Q1/68
    • C12Q1/6851C12Q2545/107C12Q2535/125C12Q2525/186
    • The present invention relates to a method for measuring the amount of a target nucleic acid in a sample using a standard which is designed to have one base difference compared with the gene of interest or a "target nucleic acid sequence." Use of such standard in combination with a method of "enhancing" the difference in the standard and the test nucleic acid sample using, for example, a base extension reaction carried right at the mutation site allowing amplification of the standard and target nucleic acids with the same efficiency and facilitating quantification of the target nucleic acid. Thereafter a means of quantifying the "enhanced" standard and target nucleic acid samples is used to determine the amount of the target nucleic acid. In the preferred embodiment, the quantification means is Mass Spectrometry.
    • 本发明涉及使用被设计为与目标基因或“目标核酸序列”相比具有一个碱基差异的标准品来测量样品中目标核酸的量的方法。 使用这样的标准与“增强”标准和测试核酸样品中差异的方法结合使用,例如,在突变位点正确携带的碱基延伸反应,允许标准和靶核酸与 相同的效率并且便于靶核酸的定量。 此后,使用量化“增强的”标准和靶核酸样品的手段来确定靶核酸的量。 在优选实施例中,量化装置是质谱仪。
    • 14. 发明申请
    • MODIFIED DIMERIC STREPTAVIDINS AND USES THEREOF
    • 改性的二甲基甲酰四环素及其用途
    • WO2006058226A9
    • 2006-07-13
    • PCT/US2005042766
    • 2005-11-23
    • UNIV BOSTONCANTOR CHARLES RASLAN FILIZ M
    • CANTOR CHARLES RASLAN FILIZ M
    • C07K14/36C12N15/10C12N15/12C12N15/62C40B40/10
    • C12N15/1044C07K14/36
    • The present invention provides novel modified streptavidin proteins, nucleic acids encoding such proteins, and uses of such proteins. Specifically, the invention provides single-chain dimeric streptavidin molecules. The invention also provides modified single-chain streptavidins with altered affinity to biotin and biotin derivatives, such as biotin-4-fluorescein. The modified single-chain dimeric streptavidin proteins can be used in analysis or composite separation either alone or in combination with ordinary streptavidin-biotin systems to visualize and/or separate composites and molecules. The single-chain streptavidin dimers of the invention also allow creating of more stable streptavidin tetramers. The single-chain streptavidin dimers of the invention can further be used as smaller sized functional streptavidin molecules in various in vivo methods, where the size of the conventional tetrameric streptavidin makes the use of such tetramers difficult or impossible. Such in vivo uses include diagnostic imaging and targeting of therapeutic molecules into individuals. The invention further provides methods of preparing and identifying novel modified single-chain streptavidin molecules.
    • 本发明提供了新的修饰的链霉抗生物素蛋白,编码这些蛋白的核酸,以及这些蛋白的用途。 具体而言,本发明提供了单链二聚体链霉抗生物素蛋白分子。 本发明还提供了对生物素和生物素衍生物如生物素-4-荧光素具有改变的亲和性的修饰的单链抗生物素蛋白链菌素。 修饰的单链二聚抗生蛋白链菌素蛋白可以单独用于分析或复合分离,或与普通链霉抗生物素蛋白 - 生物素系统组合使用,以显现和/或分离复合物和分子。 本发明的单链抗生蛋白链菌素二聚体还允许产生更稳定的抗生蛋白链菌素四聚体。 本发明的单链抗生蛋白链菌素二聚体可以进一步在各种体内方法中用作较小尺寸的功能性抗生蛋白链菌素分子,其中常规四聚链霉抗生物素蛋白的大小使得使用这种四聚体困难或不可能。 这种体内用途包括诊断成像和将治疗分子靶向至个体。 本发明进一步提供了制备和鉴定新型修饰的单链抗生蛋白链菌素分子的方法。